Cargando…
Oral PSORI-CM01, a Chinese herbal formula, plus topical sequential therapy for moderate-to-severe psoriasis vulgaris: pilot study for a double-blind, randomized, placebo-controlled trial
BACKGROUND: To provide evidence that the Chinese herbal medicine (CHM) PSORI-CM01 combined with Western medicine reduces the relapse rate of psoriasis vulgaris (PV), we plan to conduct a large-scale randomized control trial (RCT). In order to improve and perfect the RCT, this pilot study was designe...
Autores principales: | Yao, Dan-Ni, Lu, Chuan-Jian, Wen, Ze-Huai, Yan, Yu-Hong, Xuan, Mei-Ling, Li, Xiao-Yan, Li, Geng, He, Ze-Hui, Xie, Xiu-Li, Deng, Jing-Wen, Guo, Xin-Feng, Ou, Ai-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793560/ https://www.ncbi.nlm.nih.gov/pubmed/26983642 http://dx.doi.org/10.1186/s13063-016-1272-x |
Ejemplares similares
-
Formula PSORI-CM01 eliminates psoriasis by inhibiting the expression of keratinocyte cyclin B2
por: Wei, Jian-an, et al.
Publicado: (2016) -
Add‐on effect of PSORI‐CM01 to topical calcipotriol for moderate psoriasis vulgaris: A multi‐center, randomized, double‐blind pilot study
por: Parker, Shefton, et al.
Publicado: (2021) -
Identification and Quantitative Characterization of PSORI-CM01, a Chinese Medicine Formula for Psoriasis Therapy, by Liquid Chromatography Coupled with an LTQ Orbitrap Mass Spectrometer
por: Chen, Shao-Dan, et al.
Publicado: (2015) -
PSORI-CM02 Formula Increases CD4+ Foxp3+ Regulatory T Cell Frequency and Ameliorates Imiquimod-Induced Psoriasis in Mice
por: Chen, Haiming, et al.
Publicado: (2018) -
Anti-Angiogenic Efficacy of PSORI-CM02 and the Associated Mechanism in Psoriasis In Vitro and In Vivo
por: Lu, Yue, et al.
Publicado: (2021)